Top 20 global biopharma firms see 1.7 per cent market cap growth to $3.7 billion in 2024 amid policy challenges Read more
Intra-Cellular Therapies acquisition will expand J&J’s presence in neurology space, says GlobalData Read more
Diagnosed prevalent cases of HIV across 7MM to reach 2.2 million in 2033, forecasts GlobalData Read more